George Song
@Superstring Capital Management Lp
Latest period2024 - Q3ReportedManaged Assets$114.248MTotal holdings27
Assets growth rate44.02%Assets growth rate (2-Q avg)-1.76%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Superstring Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 27 positions.
Assets under management
The assets under management (AUM) of Superstring Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 114.248M in assets, with a quarterly growth rate of 44.02% and a 2-quarter average growth rate of -1.76%. The portfolio is managed by George Song, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
ZLABZai Lab Ltd
| 15.36% | $17.548M↑ Call 726,932 shares@ $24.14 avg price | Increased 237.83% |
CYTKCytokinetics Inc
| 9.98% | $11.394M 215,798 shares@ $52.8 avg price | Increased 15.02% |
TERNTerns Pharmaceuticals Inc
| 9.85% | $11.247M 1.349M shares@ $8.35 avg price | Increased 40.99% |
NVCRNovocure Ltd
| 5.38% | $6.138M 392,711 shares@ $15.64 avg price | Increased 487.09% |
BBIOBridgebio Pharma Inc
| 5.06% | $5.771M 226,684 shares@ $25.47 avg price | Increased 3.12% |
FATEFate Therapeutics Inc
| 4.5% | $5.134M 1.467M shares@ $3.5 avg price | Increased 194.95% |
TNGXTango Therapeutics Inc
| 4.04% | $4.613M 599,048 shares@ $7.71 avg price | Increased 418.34% |